BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Levillain H, Bagni O, Deroose CM, Dieudonné A, Gnesin S, Grosser OS, Kappadath SC, Kennedy A, Kokabi N, Liu DM, Madoff DC, Mahvash A, Martinez de la Cuesta A, Ng DCE, Paprottka PM, Pettinato C, Rodríguez-Fraile M, Salem R, Sangro B, Strigari L, Sze DY, de Wit van der Veen BJ, Flamen P. International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres. Eur J Nucl Med Mol Imaging 2021;48:1570-84. [PMID: 33433699 DOI: 10.1007/s00259-020-05163-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Sankhla T, Cheng B, Nezami N, Xing M, Sethi I, Bercu Z, Brandon D, Majdalany B, Schuster DM, Kokabi N. Role of Resin Microsphere Y90 Dosimetry in Predicting Objective Tumor Response, Survival and Treatment Related Toxicity in Surgically Unresectable Colorectal Liver Metastasis: A Retrospective Single Institution Study. Cancers (Basel) 2021;13:4908. [PMID: 34638392 DOI: 10.3390/cancers13194908] [Reference Citation Analysis]
2 Webster LA, Villalobos A, Majdalany BS, Bercu ZL, Gandhi RT, Kokabi N. Standard Radiation Dosimetry Models: What Interventional Radiologists Need to Know. Semin Intervent Radiol 2021;38:405-11. [PMID: 34629706 DOI: 10.1055/s-0041-1732323] [Reference Citation Analysis]
3 Zhou W, Sze DY. Gastric Outlet Obstruction Following Radioembolization: Extrahepatic Complication from Proximity to a Superficial Hepatic Tumor Treated with an Ablative Dose. J Vasc Interv Radiol 2021;32:1699-701. [PMID: 34534651 DOI: 10.1016/j.jvir.2021.09.001] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Aramburu J, Antón R, Rodríguez-Fraile M, Sangro B, Bilbao JI. Computational Fluid Dynamics Modeling of Liver Radioembolization: A Review. Cardiovasc Intervent Radiol 2022;45:12-20. [PMID: 34518913 DOI: 10.1007/s00270-021-02956-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Liu DM, Leung TW, Chow PK, Ng DC, Lee RC, Kim YH, Mao Y, Cheng YF, Teng GJ, Lau WY. Clinical consensus statement: Selective internal radiation therapy with yttrium 90 resin microspheres for hepatocellular carcinoma in Asia. Int J Surg 2022;102:106094. [PMID: 35662438 DOI: 10.1016/j.ijsu.2021.106094] [Reference Citation Analysis]
6 Zhuang KD, Tong AK, Ng DCE, Tay KH. The Role of Catheter-Directed CT-Angiography in Radioembolisation. Cardiovasc Intervent Radiol 2022. [PMID: 35595985 DOI: 10.1007/s00270-022-03157-4] [Reference Citation Analysis]
7 Knešaurek K, Martinez RB, Ghesani M. Tumour-to-normal tissue (T/N) dosimetry ratios role in assessment of 90Y selective internal radiation therapy (SIRT). Br J Radiol 2022;95:20210294. [PMID: 34762514 DOI: 10.1259/bjr.20210294] [Reference Citation Analysis]
8 Lawhn-heath C, Hope TA, Martinez J, Fung EK, Shin J, Seo Y, Flavell RR. Dosimetry in radionuclide therapy: the clinical role of measuring radiation dose. The Lancet Oncology 2022;23:e75-87. [DOI: 10.1016/s1470-2045(21)00657-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 d'Abadie P, Walrand S, Hesse M, Amini N, Lhommel R, Sawadogo K, Jamar F. Accurate non-tumoral 99mTc-MAA absorbed dose prediction to plan optimized activities in liver radioembolization using resin microspheres. Phys Med 2021;89:250-7. [PMID: 34438353 DOI: 10.1016/j.ejmp.2021.07.032] [Reference Citation Analysis]
10 Hosseini Shabanan S, Nezami N, Abdelsalam ME, Sheth RA, Odisio BC, Mahvash A, Habibollahi P. Selective Internal Radiation Therapy with Yttrium-90 for Intrahepatic Cholangiocarcinoma: A Systematic Review on Post-Treatment Dosimetry and Concomitant Chemotherapy. Current Oncology 2022;29:3825-48. [DOI: 10.3390/curroncol29060306] [Reference Citation Analysis]
11 van der Meulen NP, Strobel K, Lima TVM. New Radionuclides and Technological Advances in SPECT and PET Scanners. Cancers (Basel) 2021;13:6183. [PMID: 34944803 DOI: 10.3390/cancers13246183] [Reference Citation Analysis]
12 Cazzato RL, Hubelé F, De Marini P, Ouvrard E, Salvadori J, Addeo P, Garnon J, Kurtz JE, Greget M, Mertz L, Goichot B, Gangi A, Imperiale A. Liver-Directed Therapy for Neuroendocrine Metastases: From Interventional Radiology to Nuclear Medicine Procedures. Cancers (Basel) 2021;13:6368. [PMID: 34944988 DOI: 10.3390/cancers13246368] [Reference Citation Analysis]
13 Wong TY, Zhang KS, Gandhi RT, Collins ZS, O'Hara R, Wang EA, Vaheesan K, Matsuoka L, Sze DY, Kennedy AS, Brown DB. Long-term outcomes following 90Y Radioembolization of neuroendocrine liver metastases: evaluation of the radiation-emitting SIR-spheres in non-resectable liver tumor (RESiN) registry. BMC Cancer 2022;22:224. [PMID: 35232410 DOI: 10.1186/s12885-022-09302-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Labour J, Boissard P, Baudier T, Khayi F, Kryza D, Durebex PV, Martino SP, Mognetti T, Sarrut D, Badel JN. Yttrium-90 quantitative phantom study using digital photon counting PET. EJNMMI Phys 2021;8:56. [PMID: 34318383 DOI: 10.1186/s40658-021-00402-6] [Reference Citation Analysis]
15 Bargellini I, Boni G, Traino AC, Bozzi E, Lorenzoni G, Bianchi F, Cervelli R, Depalo T, Crocetti L, Volterrani D, Cioni R. Management of Liver Tumors during the COVID-19 Pandemic: The Added Value of Selective Internal Radiation Therapy (SIRT). J Clin Med 2021;10:4315. [PMID: 34640332 DOI: 10.3390/jcm10194315] [Reference Citation Analysis]
16 Frantz S, Matsuoka L, Vaheesan K, Petroziello M, Golzarian J, Wang E, Gandhi R, Collins Z, Brower J, Rachakonda VM, Du L, Kennedy AS, Sze DY, Lee J, Brown DB. Multicenter Evaluation of Survival and Toxicities of Hepatocellular Carcinoma following Radioembolization: Analysis of the RESiN Registry. J Vasc Interv Radiol 2021;32:845-52. [PMID: 33812981 DOI: 10.1016/j.jvir.2021.03.535] [Reference Citation Analysis]
17 Willowson KP, Eslick EM, Bailey DL. Individualised dosimetry and safety of SIRT for intrahepatic cholangiocarcinoma. EJNMMI Phys 2021;8:65. [PMID: 34519900 DOI: 10.1186/s40658-021-00406-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Gulec SA, Mcgoron AJ. Radiomicrosphere Dosimetry: Principles and Current State of the Art. Seminars in Nuclear Medicine 2022. [DOI: 10.1053/j.semnuclmed.2021.12.009] [Reference Citation Analysis]
19 Fabritius MP, Seidensticker M, Rueckel J, Heinze C, Pech M, Paprottka KJ, Paprottka PM, Topalis J, Bender A, Ricke J, Mittermeier A, Ingrisch M. Bi-Centric Independent Validation of Outcome Prediction after Radioembolization of Primary and Secondary Liver Cancer. J Clin Med 2021;10:3668. [PMID: 34441964 DOI: 10.3390/jcm10163668] [Reference Citation Analysis]
20 Hendlisz A, Sclafani F. Editorial: Radioembolization for metastatic colorectal cancer: towards maturity, at last? Curr Opin Oncol 2021;33:351-2. [PMID: 33966002 DOI: 10.1097/CCO.0000000000000749] [Reference Citation Analysis]
21 Keane G, Lam M, de Jong H. Beyond the MAA-Y90 Paradigm: The Evolution of Radioembolization Dosimetry Approaches and Scout Particles. Semin Intervent Radiol 2021;38:542-53. [PMID: 34853500 DOI: 10.1055/s-0041-1736660] [Reference Citation Analysis]
22 Gear J, McGowan D, Rojas B, Craig AJ, Smith AL, Scott CJ, Scuffam J, Aldridge M, Tipping J. The internal dosimetry user group position statement on molecular radiotherapy. Br J Radiol 2021;94:20210547. [PMID: 34433005 DOI: 10.1259/bjr.20210547] [Reference Citation Analysis]
23 Ekert K, Kloth C, Nikolaou K, Grözinger G, Horger M, Thaiss W. Rim Enhancement after Technically Successful Transarterial Chemoembolization in Hepatocellular Carcinoma: A Potential Mimic of Incomplete Embolization or Reactive Hyperemia? Tomography 2022;8:1148-58. [PMID: 35448728 DOI: 10.3390/tomography8020094] [Reference Citation Analysis]
24 Ahmadzadehfar H, Ilhan H, Lam MGEH, Sraieb M, Stegger L. Radioembolization, Principles and indications. Nuklearmedizin 2022;61:262-72. [PMID: 35354218 DOI: 10.1055/a-1759-4238] [Reference Citation Analysis]
25 Tang X, Jafargholi Rangraz E, Heeren R, Coudyzer W, Maleux G, Baete K, Verslype C, Gooding MJ, Deroose CM, Nuyts J. Segmentation-guided multi-modal registration of liver images for dose estimation in SIRT. EJNMMI Phys 2022;9. [DOI: 10.1186/s40658-022-00432-8] [Reference Citation Analysis]
26 Cicone F, Gnesin S, Cremonesi M. Dosimetry of nuclear medicine therapies: current controversies and impact on treatment optimization. Q J Nucl Med Mol Imaging 2021;65:327-32. [PMID: 34881850 DOI: 10.23736/S1824-4785.21.03418-X] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
27 d’Abadie P, Walrand S, Lhommel R, Hesse M, Borbath I, Jamar F. Optimization of the Clinical Effectiveness of Radioembolization in Hepatocellular Carcinoma with Dosimetry and Patient-Selection Criteria. Current Oncology 2022;29:2422-34. [DOI: 10.3390/curroncol29040196] [Reference Citation Analysis]
28 Subreville C, Pinaquy JB, Lapuyade B, Blanc JF, Bordenave L, Papadopoulos P, Debordeaux F. Key Role of Personalized Dosimetry in Dose Adjustment for Selective Internal Radiotherapy: Retrospective Study of Patients Treated With 90Y Resin Microspheres. Clin Nucl Med 2021;46:958-64. [PMID: 34507332 DOI: 10.1097/RLU.0000000000003892] [Reference Citation Analysis]
29 d'Abadie P, Hesse M, Louppe A, Lhommel R, Walrand S, Jamar F. Microspheres Used in Liver Radioembolization: From Conception to Clinical Effects. Molecules 2021;26:3966. [PMID: 34209590 DOI: 10.3390/molecules26133966] [Reference Citation Analysis]
30 Sharma NK, Kappadath SC, Chuong M, Folkert M, Gibbs P, Jabbour SK, Jeyarajah DR, Kennedy A, Liu D, Meyer JE, Mikell J, Patel RS, Yang G, Mourtada F. The American Brachytherapy Society consensus statement for permanent implant brachytherapy using Yttrium-90 microsphere radioembolization for liver tumors. Brachytherapy 2022. [DOI: 10.1016/j.brachy.2022.04.004] [Reference Citation Analysis]
31 Roosen J, Arntz MJ, Janssen MJR, de Jong SF, Fütterer JJ, Overduin CG, Nijsen JFW. Development of an MRI-Guided Approach to Selective Internal Radiation Therapy Using Holmium-166 Microspheres. Cancers (Basel) 2021;13:5462. [PMID: 34771626 DOI: 10.3390/cancers13215462] [Reference Citation Analysis]
32 McArdle N, Cournane S, McCavana J, Lucey J, León Vintró L. Development of a scatter correction technique for planar 99mTc-MAA imaging to improve accuracy in lung shunt fraction estimation. Phys Med 2022;99:94-101. [PMID: 35665625 DOI: 10.1016/j.ejmp.2022.05.017] [Reference Citation Analysis]
33 Wehrenberg-Klee E, Goyal L. Combining systemic and local therapies for hepatocellular carcinoma. Lancet Gastroenterol Hepatol 2021;6:976-8. [PMID: 34695376 DOI: 10.1016/S2468-1253(21)00388-5] [Reference Citation Analysis]
34 Mahvash A, Chartier S, Turco M, Habib P, Griffith S, Brown S, Kappadath SC. A prospective, multicenter, open-label, single-arm clinical trial design to evaluate the safety and efficacy of 90Y resin microspheres for the treatment of unresectable HCC: the DOORwaY90 (Duration Of Objective Response with arterial Ytrrium-90) study. BMC Gastroenterol 2022;22. [DOI: 10.1186/s12876-022-02204-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]